Recent advances and emerging therapies in anaplastic thyroid carcinoma

Anaplastic thyroid cancer is a rare and aggressive thyroid cancer with an overall survival measured in months. Because of this poor prognosis and often advanced age at presentation, these patients have traditionally been treated palliatively and referred for hospice. However, recent progress using n...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabanillas, Maria E., Zafereo, Mark, Williams, Michelle D., Ferrarotto, Renata, Dadu, Ramona, Gross, Neil, Gunn, G. Brandon, Skinner, Heath, Cote, Gilbert, Grosu, Horiana B., Iyer, Priyanka, Busaidy, Naifa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753603/
https://www.ncbi.nlm.nih.gov/pubmed/31583077
http://dx.doi.org/10.12688/f1000research.13124.1
_version_ 1783452922452901888
author Cabanillas, Maria E.
Zafereo, Mark
Williams, Michelle D.
Ferrarotto, Renata
Dadu, Ramona
Gross, Neil
Gunn, G. Brandon
Skinner, Heath
Cote, Gilbert
Grosu, Horiana B.
Iyer, Priyanka
Busaidy, Naifa L.
author_facet Cabanillas, Maria E.
Zafereo, Mark
Williams, Michelle D.
Ferrarotto, Renata
Dadu, Ramona
Gross, Neil
Gunn, G. Brandon
Skinner, Heath
Cote, Gilbert
Grosu, Horiana B.
Iyer, Priyanka
Busaidy, Naifa L.
author_sort Cabanillas, Maria E.
collection PubMed
description Anaplastic thyroid cancer is a rare and aggressive thyroid cancer with an overall survival measured in months. Because of this poor prognosis and often advanced age at presentation, these patients have traditionally been treated palliatively and referred for hospice. However, recent progress using novel therapies has energized the field, and several promising clinical trials are now available for these patients. This review will highlight this progress and the potential treatments that could pave the way to improved outcomes and quality of life for patients with this disease.
format Online
Article
Text
id pubmed-6753603
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-67536032019-10-02 Recent advances and emerging therapies in anaplastic thyroid carcinoma Cabanillas, Maria E. Zafereo, Mark Williams, Michelle D. Ferrarotto, Renata Dadu, Ramona Gross, Neil Gunn, G. Brandon Skinner, Heath Cote, Gilbert Grosu, Horiana B. Iyer, Priyanka Busaidy, Naifa L. F1000Res Review Anaplastic thyroid cancer is a rare and aggressive thyroid cancer with an overall survival measured in months. Because of this poor prognosis and often advanced age at presentation, these patients have traditionally been treated palliatively and referred for hospice. However, recent progress using novel therapies has energized the field, and several promising clinical trials are now available for these patients. This review will highlight this progress and the potential treatments that could pave the way to improved outcomes and quality of life for patients with this disease. F1000 Research Limited 2018-01-18 /pmc/articles/PMC6753603/ /pubmed/31583077 http://dx.doi.org/10.12688/f1000research.13124.1 Text en Copyright: © 2018 Cabanillas ME et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Cabanillas, Maria E.
Zafereo, Mark
Williams, Michelle D.
Ferrarotto, Renata
Dadu, Ramona
Gross, Neil
Gunn, G. Brandon
Skinner, Heath
Cote, Gilbert
Grosu, Horiana B.
Iyer, Priyanka
Busaidy, Naifa L.
Recent advances and emerging therapies in anaplastic thyroid carcinoma
title Recent advances and emerging therapies in anaplastic thyroid carcinoma
title_full Recent advances and emerging therapies in anaplastic thyroid carcinoma
title_fullStr Recent advances and emerging therapies in anaplastic thyroid carcinoma
title_full_unstemmed Recent advances and emerging therapies in anaplastic thyroid carcinoma
title_short Recent advances and emerging therapies in anaplastic thyroid carcinoma
title_sort recent advances and emerging therapies in anaplastic thyroid carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753603/
https://www.ncbi.nlm.nih.gov/pubmed/31583077
http://dx.doi.org/10.12688/f1000research.13124.1
work_keys_str_mv AT cabanillasmariae recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT zafereomark recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT williamsmichelled recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT ferrarottorenata recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT daduramona recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT grossneil recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT gunngbrandon recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT skinnerheath recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT cotegilbert recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT grosuhorianab recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT iyerpriyanka recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma
AT busaidynaifal recentadvancesandemergingtherapiesinanaplasticthyroidcarcinoma

Ejemplares similares